Will this tech stock soar after beating expectations in H1?

Should you buy this tech company after it beats guidance?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Online advertising company RhythmOne (LSE: RTHM) has reported an upbeat set of results for the first half of its financial year. They show that the company is making good progress with its strategy and with an expectations-beating performance, it could be a good time to buy.

RhythmOne’s performance for the first half of the year is expected to be materially ahead of market expectations. It now expects to generate sales of at least $80m from core mobile, video and programmatic products. Its programmatic sales will be at least $55m, which represents 45% growth year-on-year. Although its adjusted EBITDA (earnings before interest, tax, depreciation and amortisation) figure is expected to remain in the red, it’s due to be no more than $2.9m. This would represent a 60% improvement on the first half of the prior financial year.

Encouragingly, RhythmOne reported adjusted EBITDA that was in the black in the last two months of H1. This is significantly ahead of internal estimates and shows that it’s moving in the right direction. The improved performance of the company is largely the result of RhythmOne’s shift towards core mobile, video and programmatic products. This leverages its unified programmatic platform, RhythmMax and there’s more scope for growth ahead.

RhythmOne is forecast to remain lossmaking in each of the next two financial years. While this may be disappointing, the company’s moving in the right direction and investor sentiment could improve as it moves towards a black bottom line. However, this also means that the firm is relatively risky, as its financial performance remains less than optimal.

Lower risk

So it may be prudent to look elsewhere within the technology sector. One company, which offers a lower risk profile than RhythmOne, is Micro Focus (LSE: MCRO). Its bottom line has risen in each of the last five years and it’s forecast to increase by 11% over the next two years. Its merger with HPE’s Software business segment could act as a positive catalyst on its future growth outlook and boost profitability yet further.

Micro Focus offers upbeat income prospects too. It yields 2.6% from a dividend that’s covered a healthy 2.3 times by profit. This indicates that brisk dividend rises could be on the horizon – especially since Micro Focus has a relatively stable and consistent operating model. This should mean that its shares are less volatile than RhythmOne’s and also the risk of loss is lower.

Clearly, as a well-established and more mature company Micro Focus offers less upside than RhythmOne. However, its overall risk-reward profile is superior and for this reason it’s a better buy than its smaller sector peer. In the long run though, RhythmOne could deliver stunning share price growth, which makes it a sound buy for less risk-averse investors.

Peter Stephens has no position in any shares mentioned. The Motley Fool UK has recommended Micro Focus. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

British pound data
Investing Articles

Starting with nothing? Here’s why now is the perfect time to start building a passive income

Many are worried that 2026 might be a bad time to start investing in stocks and shares. Our Foolish author…

Read more »

ISA coins
Investing Articles

Decided not to bother with a Stocks and Shares ISA? You might be missing these 3 things!

With a fresh annual allowance for contributing to a Stocks and Shares ISA upon us, what might people who don't…

Read more »

GSK scientist holding lab syringe
Investing Articles

Why is everyone buying GSK shares?

GSK shares have been outperforming the FTSE 100 in 2026. Paul Summers takes a closer look and asks whether this…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

£10,000 invested in easyJet shares at the start of 2026 is now worth…

Anyone buying easyJet shares will have endured a rough ride since January. Paul Summers wonders whether things could get even…

Read more »

Close-up of a woman holding modern polymer ten, twenty and fifty pound notes.
Investing Articles

5 years ago, £5,000 bought 2,645 Barclays shares. But how many would it buy now?

Despite delivering an impressive return since April 2021, Barclays' shares have lagged the FTSE 100's other banks. James Beard considers…

Read more »

Side of boat fuelled by gas to liquids, advertising Shell GTL Fuel
Investing Articles

5 years ago, £5,000 bought 354 Shell shares. But how many would it buy now?

When it comes to Shell’s numbers, most of them are impressive. And it’s no different when looking at the recent…

Read more »

A rear view of a female in a bright yellow coat walking along the historic street known as The Shambles in York, UK which is a popular tourist destination in this Yorkshire city.
Investing Articles

I asked ChatGPT if I should buy Aviva, Diageo or BAE Systems stock and it said…

Aviva, Diageo and BAE Systems shares are popular FTSE 100 picks. But which of the three does ChatGPT like the…

Read more »

Tesla car at super charger station
Investing Articles

SpaceX’s IPO threatens to leave the Tesla share price on the forecourt

As Elon Musk starts fuelling the engines for a SpaceX IPO, could the Tesla share price get left in the…

Read more »